 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: MAYZENT (siponimod) |
|
***************************************************** |
|
#Post#: 3565-------------------------------------------------- |
|
More skin cancer reported to FDA from patients on certain oral D |
|
MTs |
|
By: agate Date: February 24, 2022, 8:21 pm |
|
--------------------------------------------------------- |
|
From Multiple Sclerosis News Today (February 22, 2022)--"More |
|
Skin Cancer Reported to FDA from Patients on Certain Oral |
|
DMTs": |
|
https://bit.ly/3sgMJr6 |
|
Mayzent (siponimod) and Gilenya (fingolimod) were the drugs |
|
where there was the most noticeable increase in skin cancer but |
|
several other MS drugs showed an increase as well. |
|
The article contains a statement that is worth noting: |
|
[quote]However, �evidence is insufficient to support a causative |
|
link,� the researchers wrote.[/quote] |
|
***************************************************** |
